Published in J Biol Chem on July 16, 2002
Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST. Proc Natl Acad Sci U S A (2004) 1.88
Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A₂ activities. Antioxid Redox Signal (2011) 1.74
Peroxiredoxin 6 phosphorylation and subsequent phospholipase A2 activity are required for agonist-mediated activation of NADPH oxidase in mouse pulmonary microvascular endothelium and alveolar macrophages. J Biol Chem (2011) 1.27
Redox signaling across cell membranes. Antioxid Redox Signal (2009) 1.15
Proteomic analysis of the supernatant of red blood cell units: the effects of storage and leucoreduction. Vox Sang (2013) 1.02
Expression of a mitochondrial peroxiredoxin prevents programmed cell death in Leishmania donovani. Eukaryot Cell (2006) 1.00
p67(phox) terminates the phospholipase A(2)-derived signal for activation of NADPH oxidase (NOX2). FASEB J (2013) 0.86
Strboh A homologue of NADPH oxidase regulates wound-induced oxidative burst and facilitates wound-healing in potato tubers. Planta (2007) 0.82
ML-7 inhibits exocytosis of superoxide-producing intracellular compartments in human neutrophils stimulated with phorbol myristate acetate in a myosin light chain kinase-independent manner. Histochem Cell Biol (2003) 0.79
Cell stress proteins in atherothrombosis. Oxid Med Cell Longev (2012) 0.77
Peroxiredoxin 6 (Prdx6) supports NADPH oxidase1 (Nox1)-based superoxide generation and cell migration. Free Radic Biol Med (2016) 0.76
Mitochondrial transmembrane potential is diminished in phorbol myristate acetate-stimulated peritoneal resident macrophages isolated from wild-type mice, but not in those from gp91-phox-deficient mice. Histochem Cell Biol (2004) 0.76
LysoPCs induce Hck- and PKCδ-mediated activation of PKCγ causing p47phox phosphorylation and membrane translocation in neutrophils. J Leukoc Biol (2016) 0.75
Transfusion-related acute lung injury: definition and review. Crit Care Med (2005) 3.98
Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood (2002) 3.18
Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med (2003) 2.93
VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis. Nat Med (2006) 2.67
Transfusion-related acute lung injury. Blood (2004) 2.65
Mammalian long-chain acyl-CoA synthetases. Exp Biol Med (Maywood) (2008) 2.28
Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family. J Lipid Res (2004) 2.08
Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med (2004) 2.01
Tropomodulin 1-null mice have a mild spherocytic elliptocytosis with appearance of tropomodulin 3 in red blood cells and disruption of the membrane skeleton. Blood (2010) 1.99
Human term placenta as a source of hematopoietic cells. Exp Biol Med (Maywood) (2009) 1.51
Hemolysis-associated pulmonary hypertension in thalassemia. Ann N Y Acad Sci (2005) 1.35
Mammalian acyl-CoA:lysophosphatidylcholine acyltransferase enzymes. Proc Natl Acad Sci U S A (2007) 1.33
Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state. Am J Hematol (2006) 1.31
Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium. J Leukoc Biol (2003) 1.25
Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood (2007) 1.17
Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME). Transfusion (2011) 1.14
Hydroxyurea and arginine therapy: impact on nitric oxide production in sickle cell disease. J Pediatr Hematol Oncol (2003) 1.14
Imaging of the diffusion of single band 3 molecules on normal and mutant erythrocytes. Blood (2009) 1.12
Activity of the acyl-CoA synthetase ACSL6 isoforms: role of the fatty acid Gate-domains. BMC Biochem (2010) 1.08
Multiple erythroid isoforms of human long-chain acyl-CoA synthetases are produced by switch of the fatty acid gate domains. BMC Mol Biol (2006) 1.06
Hydrolysis of phosphatidylserine-exposing red blood cells by secretory phospholipase A2 generates lysophosphatidic acid and results in vascular dysfunction. J Biol Chem (2005) 1.06
Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. Br J Haematol (2006) 1.04
Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension. Haematologica (2013) 0.99
In vivo reduction of erythrocyte oxidant stress in a murine model of beta-thalassemia. Haematologica (2004) 0.98
The effect of storage on the accumulation of oxidative biomarkers in donated packed red blood cells. J Trauma (2009) 0.98
Neuronal ubiquitinated intranuclear inclusions in familial and non-familial frontotemporal dementia of the motor neuron disease type associated with amyotrophic lateral sclerosis. J Neuropathol Exp Neurol (2004) 0.97
The effects of disruption of genes for peroxiredoxin-2, glutathione peroxidase-1, and catalase on erythrocyte oxidative metabolism. Free Radic Biol Med (2009) 0.96
Identification of an erythroid ATP-dependent aminophospholipid transporter. Br J Haematol (2006) 0.95
Recruitment of murine neutrophils in vivo through endogenous sialidase activity. J Biol Chem (2002) 0.93
Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease. Br J Haematol (2011) 0.92
Fetal haemoglobin augmentation in E/beta(0) thalassaemia: clinical and haematological outcome. Br J Haematol (2005) 0.92
Multipotent stromal stem cells from human placenta demonstrate high therapeutic potential. Stem Cells Transl Med (2012) 0.92
Large-scale arrays of picolitre chambers for single-cell analysis of large cell populations. Lab Chip (2010) 0.91
Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells. Br J Haematol (2004) 0.90
Generation of neutrophil priming activity by cell-containing blood components treated with pathogen reduction technology and stored in platelet additive solutions. Transfusion (2010) 0.89
A simple assay for frequency of chromosome breaks and loss (micronuclei) by flow cytometry of human reticulocytes. FASEB J (2004) 0.89
Phthalate esters used as plasticizers in packed red blood cell storage bags may lead to progressive toxin exposure and the release of pro-inflammatory cytokines. Oxid Med Cell Longev (2010) 0.89
Protein kinase C activation induces phosphatidylserine exposure on red blood cells. Biochemistry (2002) 0.89
Selective increase of autoimmune epitope expression on aged erythrocytes in mice: implications in anti-erythrocyte autoimmune responses. J Autoimmun (2002) 0.88
Altered red cell turnover in diabetic mice. J Lab Clin Med (2002) 0.88
A pilot study of subcutaneous decitabine in β-thalassemia intermedia. Blood (2011) 0.88
West Nile viremic blood donors and risk factors for subsequent West Nile fever. Vector Borne Zoonotic Dis (2007) 0.88
Phox activity of differentiated PLB-985 cells is enhanced, in an agonist specific manner, by the PLA2 activity of Prdx6-PLA2. Eur J Immunol (2012) 0.88
Formyl-Met-Leu-Phe induces calcium-dependent tyrosine phosphorylation of Rel-1 in neutrophils. Cell Calcium (2003) 0.87
ATP8A1 activity and phosphatidylserine transbilayer movement. J Receptor Ligand Channel Res (2008) 0.85
NADPH oxidase activity of neutrophil specific granules: requirements for cytosolic components and evidence of assembly during cell activation. Mol Genet Metab (2004) 0.84
Characterization of an acyl-coenzyme A binding protein predominantly expressed in human primitive progenitor cells. J Lipid Res (2008) 0.84
Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome. Hemoglobin (2006) 0.84
Phosphatidylcholine formation by LPCAT1 is regulated by Ca(2+) and the redox status of the cell. BMC Biochem (2012) 0.84
A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. Haematologica (2013) 0.84
Rac2D57N, a dominant inhibitory Rac2 mutant that inhibits p38 kinase signaling and prevents surface ruffling in bone-marrow-derived macrophages. J Cell Sci (2004) 0.82
Inability to maintain GSH pool in G6PD-deficient red cells causes futile AMPK activation and irreversible metabolic disturbance. Antioxid Redox Signal (2015) 0.82
Loss-of-function and gain-of-function phenotypes of stomatocytosis mutant RhAG F65S. Am J Physiol Cell Physiol (2011) 0.81
Measuring chromosome breaks in patients with thalassemia. Ann N Y Acad Sci (2005) 0.81
Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment. Ann N Y Acad Sci (2005) 0.80
Long term G-CSF-induced remission of ulcerative colitis-like inflammatory bowel disease in a patient with glycogen storage disease Ib and evaluation of associated neutrophil function. Pediatr Blood Cancer (2010) 0.80
Eukaryotic protein recruitment into the Chlamydia inclusion: implications for survival and growth. PLoS One (2012) 0.80
Remodeling of host phosphatidylcholine by Chlamydia acyltransferase is regulated by acyl-CoA binding protein ACBD6 associated with lipid droplets. Microbiologyopen (2015) 0.80
Cellular therapy with sequential unmanipulated donor lymphocyte infusions in drug-resistant cytomegalovirus (CMV) encephalitis. Blood (2011) 0.80
Sulphydryl modifications alter scramblase activity in murine sickle cell disease. Br J Haematol (2006) 0.79
Postinjury serum secretory phospholipase A2 correlates with hypoxemia and clinical status at 72 hours. J Am Coll Surg (2005) 0.79
Pediatric transfusion medicine: development of a critical mass. Transfusion (2008) 0.79
Bioactive lipids from stored cellular blood components: in vitro method is crucial for proper interpretation. Transfusion (2012) 0.79
Infection prevention in the cancer center. Clin Infect Dis (2013) 0.79
Rescued mice with Hb E transgene-developed red cell changes similar to human beta-thalassemia/HbE disease. Ann N Y Acad Sci (2005) 0.78
Serum C-reactive protein parallels secretory phospholipase A2 in sickle cell disease patients with vasoocclusive crisis or acute chest syndrome. Blood (2005) 0.78
Flow cytometric determination of PMCA-mediated Ca2+-extrusion in individual red blood cells. Cytometry A (2007) 0.78
Improved engraftment with minimal graft-versus-host disease after major histocompatibility complex-mismatched cord blood transplantation with photochemically treated donor lymphocytes. Exp Biol Med (Maywood) (2011) 0.78
Chronic inflammatory demyelinating polyradiculoneuropathy with tumefactive central demyelination. Muscle Nerve (2006) 0.78
Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: state of the science and planning the way forward. Biologicals (2012) 0.77
A transgenic mouse model expressing exclusively human hemoglobin E: indications of a mild oxidative stress. Blood Cells Mol Dis (2012) 0.77
Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates. Transfusion (2009) 0.76
Hydroxycarbamide-induced changes in E/beta thalassemia red blood cells. Am J Hematol (2008) 0.76
Secretory phospholipase A2: a marker of infection in febrile children presenting to a pediatric ED. Am J Emerg Med (2010) 0.76
Red cell exchange transfusion halts progressive proliferative sickle cell retinopathy in a teenaged patient with hemoglobin SC disease. Pediatr Blood Cancer (2015) 0.76
Consensus recommendations of pediatric transfusion medicine objectives for clinical pathology residency training programs. Transfusion (2009) 0.75
Research in athletes with sickle cell trait: just do it. J Appl Physiol (1985) (2012) 0.75
Oxidase activity in cord blood neutrophils: a balance between increased membrane associated cytochrome b558 and deficient cytosolic components. Pediatr Blood Cancer (2005) 0.75
RBC deformability and amino acid concentrations after hypo-osmotic challenge may reflect chronic cell hydration status in healthy young men. Physiol Rep (2013) 0.75
Therapeutic options for transfusion related acute lung injury; the potential of the G2A receptor. Curr Pharm Des (2012) 0.75
Evidence of knowledge acquisition in a cognitive flexibility-based computer learning environment. Med Educ Online (2008) 0.75
In vivo treatment with granulocyte colony-stimulating factor does not delay apoptosis in human neutrophils by increasing the expression of the vacuolar proton ATPase. J Investig Med (2002) 0.75
Photo Quiz: Fungal sinusitis in a 75-year-old neutropenic cancer patient. Clin Infect Dis (2015) 0.75
Hybrid III Lower Leg Injury Assessment Reference Curves Under Axial Impacts Using Matched-Pair Tests. Biomed Sci Instrum (2015) 0.75
Report on the international workshop on alternative methods for Leptospira vaccine potency testing: state of the science and the way forward. Biologicals (2013) 0.75
CP-64131, an aminobenzazepine with cytokine-like properties, stimulates human neutrophil functions through the p38-MAPK pathway. J Leukoc Biol (2004) 0.75
Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt. Clin Infect Dis (2006) 0.75
Pharmacoeconomics of antifungal pharmacotherapy--challenges and future directions. Expert Opin Pharmacother (2005) 0.75
Sweet syndrome in an infant with chronic granulomatous disease. J Pediatr Hematol Oncol (2012) 0.75